home.aspx
 
EVENTS

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

Adapt Pharma

Adapt Pharma is an innovative small business focused on developing cutting-edge treatments for patients with special medical conditions. Our mission is to provide simple, reliable, and accessible therapeutic options, ensuring that patients, and those who care for them, have access to the right treatment at the right time.

RELATED NEWS


With the South Korean pharma industry expanding, the size of the local pharma workforce grew by 27 percent compared to four years ago reported the Korean herald. According to the Korea Pharmaceutical Manufacturers Association, a total of 94,500 people were employed at some 842 pharmaceutical companies as of 2015, a sharp increase from 2011, when 74,000 people were employed at 822 companies....
BIOSPECTRUMASIA.COM
READ MORE

Eli Lilly and Incytes Olumiant has run up against safety hurdles in the past. But can those hurdles stop the drugmakers from adding another feather to the drugs cap, this time in the booming and increasingly competitive atopic dermatitis AD market? Adding Olumiant to standard-of-care corticosteroids significantly cleared AD trial patients skin over placebo at 16 weeks. Those were the findings from the drugs phase 3 trial Breeze-Ad7, the third of five placebo-controlled trials for Olumiant in AD,...

READ MORE

Last year was the biggest ever for digital health investment, according to a report that has been tracking the market since the beginning of the decade. According to the report by Startup Health Insights, investment in digital health has increased 14-fold since 2010. In 2018, funding for digital health was $14.6 billion, compared with just $1.2 billion in 2010, and almost $3 billion more than in 2017. The average size of deals also increased in 2018 to $21 million, a $6 million increase compared...

READ MORE

FibroGen has staked another claim to market for a new class of oral therapies for anemia associated with chronic kidney disease (CKD), after reporting a positive phase 3 trial. Roxadustat currently leading the pack in the hypoxia-inducible factor (HIF) stabilizer category met its objectives in the ALPS study, the first of three late-stage European studies being conducted by FibroGen’s partner Astellas. 

The drug outperformed placebo in its ability to boost hemoglobin (Hb) lev...

READ MORE

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has convened an Expert Working Group (EWG) to assess the risks and benefits of opioid medicines and see if current UK regulation is up to scratch. The opioid addiction crisis in the US has been linked with hundreds of thousands of deaths, with the Trump administration declaring it a national public health emergency. Though the problem is not quite as acute in the UK, the use of opioid painkillers such as codeine and fentan...

READ MORE

Patients with glioblastoma, a persistent and difficult to treat brain cancer, often end up suffering through multiple rounds of chemo and radiation therapy. Scientists at MIT have been working on harnessing the power of artificial intelligence to better optimize the therapy dosages, sparing the patients the brunt of the treatments while maintaining their clinical effectiveness. Their software, which uses a technique called reinforced learning, assesses different data points about a given patient...
MIT
READ MORE

EVENTS

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...